Neogen Corporation's Legal Challenges
Neogen Corporation is currently facing a class action lawsuit, a serious development that has drawn attention from various investors. This lawsuit is based on allegations that the company and some of its executives failed to disclose vital information during a crucial period for the company's financial performance. Investors who suffered losses during this time should be aware of their rights and the ongoing legal processes.
Details of the Class Action Lawsuit
The legal case against Neogen involves significant financial stakes for several shareholders. Investors are reminded that if they faced losses exceeding $100,000 due to this situation, they might need to act promptly to protect their interests. The deadline to file lead plaintiff applications is approaching.
If you purchased shares during the defined Class Period, which spans from early January through early June, it's essential to understand the implications of this lawsuit. The case is currently pending in the United States District Court for the Western District and could have a lasting impact on the company's reputation and future.
Impact of Financial Decline
On April 9, the company reported a notable decrease in revenue, revealing a 3.4% decline, which equals approximately $221 million. This downturn is attributed to various integration challenges faced by Neogen. Added to this, the leadership change, including the departure of the CEO, has raised concerns among shareholders regarding the company's direction and management stability.
Understanding Your Legal Rights
Investors who were affected should consider reaching out to legal experts specializing in securities litigation. Understanding your rights in these situations is crucial, especially since the company has experienced a significant share price drop following these revelations. Often, filing as a lead plaintiff in such cases could strengthen the overall legal pursuit against the company.
Background of Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC (KSF) has established itself as a leading law firm in securities litigation, with notable experience helping investors across various challenges. Their Managing Partner, Lewis Kahn, offers potential investors resources to better understand their options. KSF has a strong track record, having been recognized among the top 10 national firms for its legal expertise.
What Investors Should Do Next
For current or former shareholders of Neogen who want to explore their situation further, KSF offers avenues for no-obligation discussions regarding legal rights. It is crucial to take action before the deadline if you wish to become actively involved in the lawsuit.
Contact Information
Potential class members can connect with KSF to discuss possible claims and recoveries. They are committed to assisting investors navigate through the complexities of the claims process related to securities issues.
Frequently Asked Questions
What is the basis of the lawsuit against Neogen Corporation?
The lawsuit alleges that Neogen and its executives did not disclose critical information that impacted financial performance, resulting in investor losses.
Who can participate in the class action suit?
Investors who purchased shares of Neogen during the specified Class Period and experienced a loss greater than $100,000 may be eligible.
What are the next steps for affected investors?
Investors should contact a legal expert to understand their rights and potentially file as a lead plaintiff by the specified deadline.
When is the deadline to file a lead plaintiff application?
The deadline for filing a lead plaintiff application in this class action is September 16, 2025.
How can I learn more about the situation?
Affected investors can contact KSF for detailed guidance regarding their legal rights and potential actions they can take.
